Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Galecto Inc

GLTO
Current price
13.73 USD -0.21 USD (-1.51%)
Last closed 14.09 USD
ISIN US36322Q1076
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 14 031 766 USD
Yield for 12 month -7.73 %
1Y
3Y
5Y
10Y
15Y
GLTO
21.11.2021 - 28.11.2021

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark. Address: Ole Maaloes Vej 3, Copenhagen, Denmark, 2200

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

225 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-830 000 USD

Last Year

-490 000 USD

Current Quarter

-77 000 USD

Last Quarter

-98 000 USD

Key Figures GLTO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -21 912 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -32.17 %
PEG Ratio
Return On Equity TTM -75.57 %
Wall Street Target Price 225 USD
Revenue TTM
Book Value 21.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -23.25 USD
Diluted Eps TTM -23.25 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GLTO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GLTO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:25
Payout Ratio
Last Split Date 30.08.2024
Dividend Date

Stock Valuation GLTO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.4609
Price Book MRQ 0.5949

Financials GLTO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GLTO

For 52 weeks

10.61 USD 23.5 USD
50 Day MA 13.22 USD
Shares Short Prior Month 8 521
200 Day MA 15.72 USD
Short Ratio 0.76
Shares Short 16 907
Short Percent 1.63 %